E. Verwijk, Netherlands

Amsterdam University Medical Center Medical Psychology
Esmée Verwijk, PhD, is clinical neuropsychologist at Amsterdam UMC and assistant professor at the University of Amsterdam. She is board member of the European forum of ECT (EFFECT), member of the International Society of ECT and neurostimulation (ISEN), board member of NSWO (Dutch Society of Sleep Wake research). To understand normal and abnormal individual differences in cognitive performance, her research focuses on cognitive variability in healthy and diseased populations. Individual factors influencing cognitive performance such as sleep quality, mood and stress, as well as external factors such as cognitive changes due to brain stimulation (ECT/DBS) or caused by an illness (depression; Parkinsons; COVID-19) are of interest to her. Her goal is to integrate fundamental and clinical research in search of the predictive determinants and underlying mechanisms of individual cognitive variability.

Presenter of 2 Presentations

Symposium: Personalising ECT for Depression (ID 133) No Topic Needed

Live Q&A

Session Icon
Pre-Recorded with Live Q&A
Date
Sun, 11.04.2021
Session Time
17:30 - 19:00
Room
Channel 7
Lecture Time
18:38 - 18:58
Symposium: Personalising ECT for Depression (ID 133) No Topic Needed

S0064 - Managing ECT Related Cognitive Side Effects: An Individual Approach

Session Icon
Pre-Recorded with Live Q&A
Date
Sun, 11.04.2021
Session Time
17:30 - 19:00
Room
Channel 7
Lecture Time
18:21 - 18:38

ABSTRACT

Abstract Body

Electroconvulsive brain stimulation may represent the strongest manipulation available to study brain plasticity in humans. Brain plasticity induced by electroconvulsive brain stimulation, profoundly improves disturbed emotion and motivation in patients with depression. Electroconvulsive therapy (ECT) is a highly effective and safe treatment for psychiatric disorders like severe depression. However, there is ongoing concern about the negative impact of ECT on brain function and cognition that is, surprisingly, only seen in a part of the treated patients. After 80 years of research on ECT, virtually nothing is known about the mechanisms underlying these strong individual differences in cognitive changes induced by ECT. A first step would be to better quantify the pattern and severity of the adverse cognitive outcomes in order to better distinguish patients that suffer from adverse cognitive outcomes from those that do not or even improve. By better distinguishing of these subgroups, a second step towards understanding can be taken: to identify the factors that predict adverse cognitive outcomes. Our research aims to advance understanding of the mechanisms of cognitive plasticity and reveal the pre-treatment profiles that render a patient cognitive vulnerable or resilient.

Hide